*Institute for Surgical Technology and Biomechanics, University of Bern, Berne, Switzerland; †Bone and Stem Cell Research Group, Center for Applied Biotechnology and Molecular Medicine, University of Zurich, Zurich, Switzerland; and ‡Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.
Spine (Phila Pa 1976). 2013 Oct 15;38(22):E1377-87. doi: 10.1097/BRS.0b013e31829ffde8.
In vitro study to develop an intervertebral disc degeneration organ culture model, using coccygeal bovine intervertebral discs (IVDs) and injection of proteolytic enzymes MMP-3, ADAMTS-4, and HTRA1.
This study aimed to develop an in vitro model of enzyme-mediated intervertebral disc degeneration to mimic the clinical outcome in humans for investigation of therapeutic treatment options.
Bovine IVDs are comparable with human IVDs in terms of cell composition and biomechanical behavior. Researchers injected papain and trypsin into them to create an intervertebral disc degeneration model with a degenerated nucleus pulposus (NP) area. They achieved macroscopic cavities as well as a loss of glycosaminoglycans (GAGs). However, none of these enzymes are clinically relevant.
Bovine IVDs were harvested maintaining the endplates. Active forms of MMP-3, ADAMTS-4, and HTRA1 were injected at a dose of 10 μg/mL each. Phosphate-buffered saline was injected as a control. Discs were cultured for 8 days and loaded diurnally (days 1-4 with ≈0.4 MPa for 16 hr) and left under free swelling condition from days 4 to 8 to avoid expected artifacts because of dehydration of the NP. Outcome parameters included disc height, metabolic cell activity, DNA content, GAG content, total collagen content, relative gene expression, and histological investigation.
The mean metabolic cell activity was significantly lower in the NP area of discs injected with ADAMTS-4 than the day 0 control discs. Disc height was decreased after injection with HTRA1 and was significantly correlated with changes in GAG/DNA of the NP tissue. Total collagen content tended to be lower in groups injected with ADAMTS4 and MMP-3.
MMP-3, ADAMTS-4, and HTRA1 provoked neither visible matrix degradation nor major shifts in gene expression. However, cell activity was significantly reduced and HTRA1 induced loss of disc height that positively correlated with changes in GAG/DNA content. The use of higher doses of these enzymes or a combination thereof may, therefore, be necessary to induce disc degeneration.
体外研究开发椎间盘退行性变器官培养模型,使用尾骨牛椎间盘(IVD)和注射蛋白水解酶 MMP-3、ADAMTS-4 和 HTRA1。
本研究旨在开发一种酶介导的椎间盘退行性变体外模型,以模拟人类的临床结果,用于研究治疗选择。
牛椎间盘在细胞组成和生物力学行为方面与人类椎间盘相似。研究人员向其注射木瓜蛋白酶和胰蛋白酶,以创建具有退行性核髓(NP)区域的椎间盘退行性变模型。他们实现了宏观空腔以及糖胺聚糖(GAG)的丢失。然而,这些酶都没有临床意义。
牛椎间盘收获时保留终板。以 10 μg/mL 的剂量分别注射活性形式的 MMP-3、ADAMTS-4 和 HTRA1。注射磷酸盐缓冲盐水作为对照。椎间盘培养 8 天,每天加载(第 1-4 天,NP 约 0.4 MPa,16 小时),第 4-8 天在自由膨胀条件下,以避免由于 NP 脱水而产生预期的假象。结果参数包括椎间盘高度、代谢细胞活性、DNA 含量、GAG 含量、总胶原含量、相对基因表达和组织学研究。
与第 0 天对照椎间盘相比,注射 ADAMTS-4 的 NP 区的平均代谢细胞活性显着降低。注射 HTRA1 后,椎间盘高度降低,与 NP 组织中 GAG/DNA 的变化显着相关。注射 ADAMTS4 和 MMP-3 的组的总胶原含量往往较低。
MMP-3、ADAMTS-4 和 HTRA1 既没有引起明显的基质降解,也没有引起主要的基因表达变化。然而,细胞活性显着降低,HTRA1 诱导的椎间盘高度丧失与 GAG/DNA 含量的变化呈正相关。因此,可能需要使用更高剂量的这些酶或其组合来诱导椎间盘退变。